Prince Pharmaceutical Ratios and Metrics

Market cap in millions TWD. Fiscal year is January - December.

Millions TWD. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	May '26 May 7, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Market Capitalization	1,133	1,138	802	1,267	-	-
Market Cap Growth	59.13%	42.01%	-36.72%	-	-	-
Enterprise Value	1,402	1,502	1,180	1,670	-	-
Last Close Price	30.95	31.10	21.90	34.68	-	-
PE Ratio	11.86	11.82	-	82.75	-	-
PS Ratio	1.07	1.08	1.16	1.68	-	-
PB Ratio	1.35	1.36	1.11	1.64	-	-
P/TBV Ratio	1.35	1.36	1.11	1.64	-	-
P/FCF Ratio	15.78	15.85	28.42	2827.58	-	-
P/OCF Ratio	12.58	12.64	17.35	20.27	-	-
EV/Sales Ratio	1.33	1.42	1.71	2.22	-	-
EV/EBITDA Ratio	8.13	9.18	259.75	21.99	-	-
EV/EBIT Ratio	12.65	13.55	-	64.79	-	-
EV/FCF Ratio	19.53	20.92	41.83	3728.36	-	-
Debt / Equity Ratio	0.50	0.50	0.64	0.63	0.80	0.94
Debt / EBITDA Ratio	2.45	2.45	35.06	5.81	4.35	12.80
Debt / FCF Ratio	5.88	5.88	16.33	1094.55	7.25	409.55
Net Debt / Equity Ratio	0.32	0.32	0.50	0.48	0.69	0.82
Net Debt / EBITDA Ratio	1.65	1.65	78.80	4.84	3.97	12.32
Net Debt / FCF Ratio	3.75	3.75	12.69	820.97	6.26	357.09
Asset Turnover	0.74	0.74	0.50	0.56	0.55	0.35
Inventory Turnover	4.78	4.78	4.34	4.11	3.68	2.79
Quick Ratio	1.13	1.13	0.94	1.09	0.76	0.67
Current Ratio	1.81	1.81	1.56	1.85	1.59	1.37
Return on Equity (ROE)	12.34%	12.34%	-7.16%	2.14%	8.18%	-1.37%
Return on Assets (ROA)	4.86%	4.86%	-2.24%	1.19%	3.26%	-0.06%
Return on Invested Capital (ROIC)	9.20%	9.32%	-4.44%	1.83%	4.93%	-0.10%
Return on Capital Employed (ROCE)	9.30%	9.30%	-4.40%	2.20%	6.10%	-0.10%
Earnings Yield	8.50%	8.46%	-6.68%	1.21%	-	-
FCF Yield	6.34%	6.31%	3.52%	0.03%	-	-
Dividend Yield	-	-	-	0.72%	-	-
Payout Ratio	-	-	-	35.46%	-	-
Buyback Yield / Dilution	-1.03%	-1.03%	-0.09%	-9.66%	-0.41%	-1.45%
Total Shareholder Return	-1.03%	-1.03%	-0.09%	-8.94%	-0.41%	-1.45%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.